Literature DB >> 20728418

Revised UK guidelines for the management of cutaneous melanoma 2010.

J R Marsden1, J A Newton-Bishop, L Burrows, M Cook, P G Corrie, N H Cox, M E Gore, P Lorigan, R Mackie, P Nathan, H Peach, B Powell, C Walker.   

Abstract

These guidelines for the management of cutaneous melanoma present an evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiology, diagnosis, investigation, and follow-up. Copyright 2010 British Association of Plastic, Reconstructive and Aesthetic Surgeons and British Association of Dermatologists. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728418     DOI: 10.1016/j.bjps.2010.07.006

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  26 in total

1.  Quality of Cancer Surveillance Clinical Practice Guidelines: Specificity and Consistency of Recommendations.

Authors:  Ryan P Merkow; Deborah Korenstein; Rubaya Yeahia; Peter B Bach; Shrujal S Baxi
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

Review 2.  Follow-up in patients with low-risk cutaneous melanoma: is it worth it?

Authors:  Ulrike Leiter; Thomas Eigentler; Claus Garbe
Journal:  Melanoma Manag       Date:  2014-12-04

Review 3.  Radiation therapy for cutaneous melanoma.

Authors:  Christopher A Barker; Nancy Y Lee
Journal:  Dermatol Clin       Date:  2012-06-07       Impact factor: 3.478

Review 4.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

5.  Prognostic significance of β2-adrenergic receptor expression in malignant melanoma.

Authors:  Akira Shimizu; Kyoichi Kaira; Keita Mori; Madoka Kato; Kimihiro Shimizu; Masahito Yasuda; Ayumi Takahashi; Tetsunari Oyama; Takayuki Asao; Osamu Ishikawa
Journal:  Tumour Biol       Date:  2015-11-23

Review 6.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

7.  An incidental finding of a nodal recurrence of cutaneous malignant melanoma after a 45-year disease-free period.

Authors:  Jenny Goodenough; Caroline Louise Cozon; Se Hwang Liew
Journal:  BMJ Case Rep       Date:  2014-06-03

Review 8.  Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Authors:  Amy A Mrazek; Celia Chao
Journal:  Surg Clin North Am       Date:  2014-08-05       Impact factor: 2.741

9.  Melanoma in organ transplant recipients: incidence, outcomes and management considerations.

Authors:  Faisal R Ali; John T Lear
Journal:  J Skin Cancer       Date:  2012-11-25

10.  Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary team.

Authors:  J J Cubitt; A A Khan; E Royston; M Rughani; M R Middleton; P G Budny
Journal:  J Skin Cancer       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.